Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Grothey

Showing results (181-190 of 304) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107Axel Grothey, Eric E Hedrick, Robert D Mass, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2009
Phase 2 trial of docetaxel, gemcitabine, and oxaliplatin combination chemotherapy in platinum- and paclitaxel-pretreated epithelial ovarian cancerGregor Seliger, Lutz P Mueller, Thomas Kegel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancerEvanthia Galanis, Stephanie K Carlson, Nathan R Foster, et al.
Cancer|March 3, 2011
Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! onlineSharlene Gill, Charles Loprinzi, Hagen Kennecke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data setMichael J O'Connell, Megan E Campbell, Richard M Goldberg, et al.
Annals of Surgical Oncology|August 29, 2020
Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric CancerJustin A Drake, Zachary E Stiles, Miriam W Tsao, et al.
Investigational New Drugs|September 13, 2014
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulationsTakayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2007
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study GroupRainer Porschen, Hendrik-Tobias Arkenau, Stephan Kubicka, et al.
The Oncologist|December 19, 2019
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal CancerMohamed E Salem, Francesca Battaglin, Richard M Goldberg, et al.
The Journal of Supportive Oncology|April 7, 2007
Symptom control trials: a 20-year experienceCharles L Loprinzi, Debra L Barton, Aminah Jatoi, et al.
Pageof 31

Showing results (181-190 of 304) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107Axel Grothey, Eric E Hedrick, Robert D Mass, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2009
Phase 2 trial of docetaxel, gemcitabine, and oxaliplatin combination chemotherapy in platinum- and paclitaxel-pretreated epithelial ovarian cancerGregor Seliger, Lutz P Mueller, Thomas Kegel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancerEvanthia Galanis, Stephanie K Carlson, Nathan R Foster, et al.
Cancer|March 3, 2011
Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! onlineSharlene Gill, Charles Loprinzi, Hagen Kennecke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data setMichael J O'Connell, Megan E Campbell, Richard M Goldberg, et al.
Annals of Surgical Oncology|August 29, 2020
Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric CancerJustin A Drake, Zachary E Stiles, Miriam W Tsao, et al.
Investigational New Drugs|September 13, 2014
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulationsTakayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2007
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study GroupRainer Porschen, Hendrik-Tobias Arkenau, Stephan Kubicka, et al.
The Oncologist|December 19, 2019
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal CancerMohamed E Salem, Francesca Battaglin, Richard M Goldberg, et al.
The Journal of Supportive Oncology|April 7, 2007
Symptom control trials: a 20-year experienceCharles L Loprinzi, Debra L Barton, Aminah Jatoi, et al.
Pageof 31